Loading...

IMRX IMMUNEERING CORP Earnings Reports 8-K Filing

MMNR

MRX

IMMUNEERING CORP

(IMRX)

2025 8-K

Financial Results Report

Clinical Trial Update

Financial Results Announced

Stock Offering Details

Securities Purchase Agreement

Private Placement Raised

Quarterly Results Update

Clinical Trials

Financial Statements

Financial Results

Clinical Trial Update

Clinical Trial Update

Financial Results

Director Appointment

Clinical Trial Update

Financial Results Announcement

Annual Meeting of Stockholders

Repricing of Options

Appointment of Director

Financial Results Announcement

Amendments to Bylaws

Financial Results Announcement

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Public Offering

Results of Operations and F...

Financial Results Announcement

External Links:

On November 12, 2025, Immuneering Corporation reported its financial results for the quarter ending September 30, 2025, including operational updates. This filing is important for investors to gauge the company's performance and future strategies.

AI Assistant

IMMUNEERING CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.